Proscia, a digital and computational pathology solutions company, introduced an automated quality control application that leverages artificial intelligence (AI) to improve quality and efficiency in data-driven drug development. The company has also released an updated version of its Concentriq for Research platform to unify global pathology operations further and centralize data across the connected enterprise.